Remarks on the Design and Analyses of Longitudinal Studies for Cancer Patients with Anorexia and Weight Loss

Overview

Journal J Cachexia Sarcopenia Muscle

Date 2019 Aug 21

PMID 31429197

Citations 3

Authors

Jennifer G Le-Rademacher

Elizabeth M Storrick

Aminah Jatoi

Affiliations

Soon will be listed here.

Abstract

Longitudinal data serve an important role in understanding the cancer anorexia weight loss syndrome and in testing interventions to palliative and treat patients who develop this syndrome. The element of time and the interrelatedness of data points define longitudinal data and add to the richness of this type of data. However, longitudinal data can also give rise to non-random, missing data that can lead to flawed conclusions. This paper discusses these issues and suggests practical considerations for design and analysis of longitudinal cancer anorexia weight loss studies.

Citing Articles

A triple-masked, two-center, randomized parallel clinical trial to assess the superiority of eight weeks of grape seed flour supplementation against placebo for weight loss attenuation during perioperative period in patients with cachexia associated....

Malta F, Goncalves D Front Endocrinol (Lausanne). 2024; 14:1146479.

PMID: 38313843 PMC: 10834683. DOI: 10.3389/fendo.2023.1146479.

Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer.

Lee J, Lin J, Wu M, Chang C, Jan Y, Chen Y Cancers (Basel). 2020; 12(3).

PMID: 32150938 PMC: 7139727. DOI: 10.3390/cancers12030595.

Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss.

Le-Rademacher J, Storrick E, Jatoi A J Cachexia Sarcopenia Muscle. 2019; 10(6):1175-1182.

PMID: 31429197 PMC: 6903440. DOI: 10.1002/jcsm.12480.

References

Long C, Boulom V, Albadawi H, Tsai S, Yoo H, Oklu R . Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes. Ann Surg. 2013; 258(6):1087-95. PMC: 3773522. DOI: 10.1097/SLA.0b013e31828cced3. View

Antoun S, Birdsell L, Sawyer M, Venner P, Escudier B, Baracos V . Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol. 2010; 28(6):1054-60. DOI: 10.1200/JCO.2009.24.9730. View

Sloan J . Asking the obvious questions regarding patient burden. J Clin Oncol. 2002; 20(1):4-6. DOI: 10.1200/JCO.2002.20.1.4. View

Fearon K, Barber M, Moses A, Ahmedzai S, Taylor G, Tisdale M . Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006; 24(21):3401-7. DOI: 10.1200/JCO.2005.04.5724. View

Son H, Friedmann E, Thomas S . Application of pattern mixture models to address missing data in longitudinal data analysis using SPSS. Nurs Res. 2012; 61(3):195-203. DOI: 10.1097/NNR.0b013e3182541d8c. View

von Haehling S, Morley J, Coats A, Anker S . Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017. J Cachexia Sarcopenia Muscle. 2017; 8(6):1081-1083. PMC: 5700441. DOI: 10.1002/jcsm.12261. View

Zeger S, Liang K, Albert P . Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988; 44(4):1049-60. View

Jatoi A, Rowland K, Loprinzi C, Sloan J, Dakhil S, MacDonald N . An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004; 22(12):2469-76. DOI: 10.1200/JCO.2004.06.024. View

Temel J, Abernethy A, Currow D, Friend J, Duus E, Yan Y . Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016; 17(4):519-531. DOI: 10.1016/S1470-2045(15)00558-6. View

10.

Le-Rademacher J, Crawford J, Evans W, Jatoi A . Overcoming obstacles in the design of cancer anorexia/weight loss trials. Crit Rev Oncol Hematol. 2017; 117:30-37. PMC: 5561667. DOI: 10.1016/j.critrevonc.2017.06.008. View

11.

Le-Rademacher J, Storrick E, Jatoi A . Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss. J Cachexia Sarcopenia Muscle. 2019; 10(6):1175-1182. PMC: 6903440. DOI: 10.1002/jcsm.12480. View

12.

Young R, Johnson D . Handling Missing Values in Longitudinal Panel Data With Multiple Imputation. J Marriage Fam. 2015; 77(1):277-294. PMC: 4477955. DOI: 10.1111/jomf.12144. View

13.

Escudier B, Eisen T, Stadler W, Szczylik C, Oudard S, Siebels M . Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007; 356(2):125-34. DOI: 10.1056/NEJMoa060655. View

14.

Banks H, Hu S, Rosenberg E . A Dynamical Modeling Approach for Analysis of Longitudinal Clinical Trials in the Presence of Missing Endpoints. Appl Math Lett. 2017; 63:109-117. PMC: 5363994. DOI: 10.1016/j.aml.2016.07.002. View

15.

Lu N, Tang W, He H, Yu Q, Crits-Christoph P, Zhang H . On the impact of parametric assumptions and robust alternatives for longitudinal data analysis. Biom J. 2009; 51(4):627-43. PMC: 2875790. DOI: 10.1002/bimj.200800186. View

16.

Baracos V, DEVIVO C, Hoyle D, GOLDBERG A . Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol. 1995; 268(5 Pt 1):E996-1006. DOI: 10.1152/ajpendo.1995.268.5.E996. View

17.

Pirinen E, Canto C, Jo Y, Morato L, Zhang H, Menzies K . Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014; 19(6):1034-41. PMC: 4047186. DOI: 10.1016/j.cmet.2014.04.002. View

18.

DeSouza C, Legedza A, Sankoh A . An overview of practical approaches for handling missing data in clinical trials. J Biopharm Stat. 2010; 19(6):1055-73. DOI: 10.1080/10543400903242795. View

19.

Enders C . Multiple imputation as a flexible tool for missing data handling in clinical research. Behav Res Ther. 2016; 98:4-18. DOI: 10.1016/j.brat.2016.11.008. View

20.

Mantovani G, Maccio A, Madeddu C, Serpe R, Massa E, Dessi M . Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist. 2010; 15(2):200-11. PMC: 3227938. DOI: 10.1634/theoncologist.2009-0153. View